OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis
Yongsheng Yu, Yü Liu, Weishuai An, et al.
Journal of Clinical Investigation (2018) Vol. 129, Iss. 2, pp. 546-555
Open Access | Times Cited: 299

Showing 1-25 of 299 citing articles:

The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout, Jason D. Katz, Shankar Venkatraman, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 9, pp. 548-569
Open Access | Times Cited: 1309

Molecular mechanisms and cellular functions of cGAS–STING signalling
Karl‐Peter Hopfner, Veit Hornung
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 9, pp. 501-521
Closed Access | Times Cited: 1276

cGAS in action: Expanding roles in immunity and inflammation
Andrea Ablasser, Zhijian J. Chen
Science (2019) Vol. 363, Iss. 6431
Closed Access | Times Cited: 794

Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen, Joeri Lambrecht, Cynthia Ju, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 45-56
Open Access | Times Cited: 465

Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
Hiroshi Maekawa, Tsuyoshi Inoue, Haruki Ouchi, et al.
Cell Reports (2019) Vol. 29, Iss. 5, pp. 1261-1273.e6
Open Access | Times Cited: 425

Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling
Hongxu Xian, Kosuke Watari, Elsa Sánchez‐López, et al.
Immunity (2022) Vol. 55, Iss. 8, pp. 1370-1385.e8
Open Access | Times Cited: 356

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Gopanandan Parthasarathy, Xavier S. Revelo, Harmeet Malhi
Hepatology Communications (2020) Vol. 4, Iss. 4, pp. 478-492
Open Access | Times Cited: 344

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Dongshan Wan, Wei Jiang, Junwei Hao
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 205

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 198

The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism
Juli Bai, Feng Liu
Diabetes (2019) Vol. 68, Iss. 6, pp. 1099-1108
Open Access | Times Cited: 191

Cellular functions of cGAS-STING signaling
Chen Chen, Pinglong Xu
Trends in Cell Biology (2022) Vol. 33, Iss. 8, pp. 630-648
Closed Access | Times Cited: 189

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
Patrick Kwabena Oduro, Xianxian Zheng, Jinna Wei, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 50-75
Open Access | Times Cited: 167

Role of the cGAS–STING pathway in systemic and organ-specific diseases
Sladjana Skopelja‐Gardner, Jie An, Keith B. Elkon
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 558-572
Open Access | Times Cited: 166

Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
Nadine Gehrke, Jörn M. Schattenberg
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1929-1947.e6
Closed Access | Times Cited: 158

Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152

Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 147

Macrophage Phenotype and Function in Liver Disorder
Lang Dou, Xiaomin Shi, Xiaoshun He, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 138

Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
Estefanía de Gregorio, Anna Colell, Albert Morales, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3858-3858
Open Access | Times Cited: 137

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 128

Hepatic macrophages: Key players in the development and progression of liver fibrosis
Da Cheng, Jin Chai, Huiwen Wang, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2279-2294
Open Access | Times Cited: 125

The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
Sylwia Ziółkowska, Agata Binienda, Maciej Jabłkowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11128-11128
Open Access | Times Cited: 113

Impact of intracellular innate immune receptors on immunometabolism
Wei-Chun Chou, Elena Rampanelli, Xin Li, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 3, pp. 337-351
Open Access | Times Cited: 109

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy
Zili Zhang, Haifeng Zhou, Xiaohu Ouyang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 88

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Lili Yu, Wei Hong, Shen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 79

Page 1 - Next Page

Scroll to top